DOWN-REGULATION OF PROGESTIN RECEPTORS IN GUINEA-PIG BRAIN - NEW FINDINGS USING AN IMMUNOCYTOCHEMICAL TECHNIQUE

Progesterone injection in estradiol‐primed, ovariectomized guinea pigs results in down‐regulation of hypothalamic progestin receptors determined by in vitro binding assays. In order to determine if progesterone also decreases immunostaining of progestin receptors and if progestin receptors are down‐regulated preferentially in particular neuroanatomical areas, ovariectomized guinea pigs were injected with doses of estradiol benzoate (10 μg at 42 h before progesterone injection) and progesterone (500 μg at 4, 12, or 24 h before perfusion) that reliably induce the expression of lordosis and subsequent behavioral refractoriness to progesterone. Progestin receptor‐immunoreactive cells were counted in sections from discrete parts of the preoptic area and hypothalamus. As expected, estradiol dramatically increased cell nuclear, and, to a lesser extent, cytoplasmic, immunostaining in defined regions of the preoptic area and hypothalamus. By 12 h after progesterone injection, the number of progestin receptor‐immunoreactive cells had decreased in some areas, but not others. The rostral and caudal aspects of the ventrolateral hypothalamus were particularly responsive showing a substantial decrease in progestin receptor‐immunoreactivity by 12 h after injection. No decreases in the progestin receptor‐immunoreactive cell number were observed in any of the preoptic regions examined, although obvious decreases in immunostaining intensity were seen. The results of these immunocytochemical experiments extend earlier findings from in vitro progestin binding experiments and demonstrate that as with progestin binding, progestin receptor‐immunoreactivity decreases when progesterone is injected in a behavioral desensitization procedure. Furthermore, they point to the ventrolateral hypothalamus as one site in which the down‐regulation of progestin receptors may be particularly responsive to progesterone. Copyright © 1990 John Wiley & Sons, Inc.